搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
来自MSN
1 天
This Rare Disease Could Be Draining Your Energy- Are You At Risk?
Addison’s disease is a rare autoimmune disorder where the adrenal glands don’t produce enough vital hormones, causing fatigue ...
6 天
on MSN
Large-scale data analysis links rare diseases to higher COVID-19 mortality risk
An England-wide study of over 58 million people has identified eight rare diseases that carry significantly increased risks ...
5 天
Guillain-Barre syndrome claims 3 lives in Kolkata, over 120 cases in Maharashtra: How does ...
Cases of Guillain-Barre Syndrome (GBS) are on the rise, triggering concern among health officials. As of January 29, a total ...
frontline.thehindu
5 天
Guillain-Barré Syndrome: Is this autoimmune disorder curable?
Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...
7 天
Patient with rare autoimmune condition treated with hybrid surgery
Rare combined surgical procedures for thyroid complications and orbital decompression performed successfully in Odisha woman.
3 天
on MSN
Sick and wounded Palestinians leave Gaza as Rafah crossing reopens
Thirty-seven sick and wounded Palestinians have left Gaza for medical treatment in Egypt following the reopening of the Rafah ...
stocknews
2 天
3 Niche Healthcare Stocks Tackling Rare Diseases
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
News Medical
12 天
What is an Orphan Drug? A Guide to Rare Disease Therapies
Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...
Yahoo Finance
9 天
AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa ...
Ltd., a leading Japanese pharmaceutical company with extensive experience in marketing rare disease therapeutics in the U.S. Under the terms of the agreement, Nippon Shinyaku received an option to ...
9 天
AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa ...
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈